Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel compounds inhibit estrogen formation and action.

C Labrie1, C Martel, J M Dufour

  • 1MRC Group in Molecular Endocrinology, CHUL Research Center, Quebec, Canada.

Cancer Research
|February 1, 1992
PubMed
Summary

New estrogen derivatives show pure antiestrogenic activity and inhibit estrogen formation. These compounds offer a dual-action approach for improved endocrine therapy in breast and other estrogen-sensitive cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the proximity of alcohol outlets to schools after the introduction of convenience store alcohol sales in Ontario, Canada: A descriptive study.

Public health·2026
Same author

Examining Erectile Disorder Manifestations and the Impact of Point-Of-View in Virtual Reality Erotica.

Journal of sex research·2025
Same author

Plant-based enveloped Ara h 2 bioparticles display exceptional hypo-allergenicity.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2023
Same author

[Single dose of misoprostol for abortion until 9 weeks of gestation].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.

Physical review letters·2022
Same author

[How i do… laparotomy omentosplenectomy during complete cytoreductive surgery?]

Gynecologie, obstetrique, fertilite & senologie·2022

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Estrogens are key drivers in human breast cancer development.
  • Current antiestrogen therapies have limitations due to mixed estrogenic/antiestrogenic effects.
  • There is a need for more effective endocrine therapies for estrogen-sensitive cancers.

Purpose of the Study:

  • To evaluate novel estrogen derivatives for their therapeutic potential.
  • To investigate compounds with dual inhibitory actions on estrogen receptors and estrogen formation.
  • To explore improved treatments for breast cancer and other estrogen-sensitive diseases.

Main Methods:

  • In vivo mouse uterus assay to assess antiestrogenic activity.
  • Evaluation of inhibitory effects on 17 beta-hydroxysteroid dehydrogenase (17β-HSD) activity.

Related Experiment Videos

  • Synthesis and testing of new estrogen derivatives.

    • Main Results:

    • New estrogen derivatives demonstrated pure antiestrogenic activity.
    • These compounds potently inhibited 17 beta-hydroxysteroid dehydrogenase activity.
    • The identified compounds possess a dual mechanism of action.

    Conclusions:

    • Novel estrogen derivatives exhibit dual inhibitory effects on estrogen receptors and estrogen formation.
    • These compounds represent promising candidates for improved endocrine therapy.
    • Potential applications include breast cancer, other estrogen-sensitive malignancies, and nonmalignant diseases.